Table 2.
Significant metabolic pathways observed in groundnut before and after infection with Passalora personata (Pathway analysis using Metaboanalyst 4.0)
| No | Pathway name | Total | Hits | -log(p) | Impact |
|---|---|---|---|---|---|
| 1 | Linoleic acid metabolism | 4 | 1.000 | 1.866 | 0.667 |
| 2 | Flavone and flavonol biosynthesis | 10 | 2.000 | 2.804 | 0.625 |
| 3 | Cutin, suberine and wax biosynthesis | 18 | 3.000 | 3.359 | 0.286 |
| 4 | Pentose and glucuronate interconversions | 16 | 3.000 | 3.677 | 0.143 |
| 5 | Starch and sucrose metabolism | 22 | 3.000 | 2.840 | 0.143 |
| 6 | Stilbenoid, diarylheptanoid and gingerol biosynthesis | 8 | 1.000 | 1.252 | 0.125 |
| 7 | Ascorbate and aldarate metabolism | 18 | 2.000 | 1.788 | 0.111 |
| 8 | Citrate cycle (TCA cycle) | 20 | 3.000 | 3.083 | 0.107 |
| 9 | Fructose and mannose metabolism | 20 | 2.000 | 1.623 | 0.100 |
| 10 | Inositol phosphate metabolism | 28 | 2.000 | 1.135 | 0.097 |
| 11 | Phenylpropanoid biosynthesis | 46 | 4.000 | 2.147 | 0.091 |
| 12 | Galactose metabolism | 27 | 6.000 | 7.471 | 0.086 |
| 13 | alpha-Linolenic acid metabolism | 28 | 1.000 | 0.364 | 0.083 |
| 14 | Pentose phosphate pathway | 19 | 3.000 | 3.216 | 0.077 |
| 15 | Aminoacyl-tRNA biosynthesis | 46 | 2.000 | 0.556 | 0.074 |
| 16 | Butanoate metabolism | 17 | 2.000 | 1.880 | 0.071 |
| 17 | Amino sugar and nucleotide sugar metabolism | 50 | 4.000 | 1.922 | 0.067 |
| 18 | Glyoxylate and dicarboxylate metabolism | 29 | 3.000 | 2.177 | 0.065 |
| 19 | Arginine and proline metabolism | 34 | 1.000 | 0.269 | 0.057 |
| 20 | Glycine, serine and threonine metabolism | 33 | 1.000 | 0.283 | 0.054 |
| 21 | Valine, leucine and isoleucine biosynthesis | 22 | 1.000 | 0.501 | 0.050 |
| 22 | Propanoate metabolism | 20 | 2.000 | 1.623 | 0.045 |
| 23 | Sesquiterpenoid and triterpenoid biosynthesis | 24 | 1.000 | 0.449 | 0.045 |
| 24 | Flavonoid biosynthesis | 47 | 4.000 | 2.088 | 0.041 |
| 25 | Pyrimidine metabolism | 38 | 1.000 | 0.221 | 0.040 |
| 26 | Carbon fixation in photosynthetic organisms | 21 | 1.000 | 0.530 | 0.031 |
| 27 | Phosphatidylinositol signaling system | 26 | 1.000 | 0.404 | 0.031 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis | 38 | 1.000 | 0.221 | 0.029 |
| 29 | Steroid biosynthesis | 45 | 2.000 | 0.578 | 0.024 |
| 30 | Fatty acid degradation | 37 | 1.000 | 0.232 | 0.022 |
| 31 | Fatty acid biosynthesis | 56 | 4.000 | 1.633 | 0.014 |
| 32 | Biosynthesis of unsaturated fatty acids | 22 | 5.000 | 6.481 | 0.000 |
| 33 | Alanine, aspartate and glutamate metabolism | 22 | 2.000 | 1.478 | 0.000 |
| 34 | Sulfur metabolism | 15 | 1.000 | 0.757 | 0.000 |
| 35 | Tyrosine metabolism | 16 | 1.000 | 0.711 | 0.000 |
| 36 | Arginine biosynthesis | 18 | 1.000 | 0.630 | 0.000 |
| 37 | Pyruvate metabolism | 22 | 1.000 | 0.501 | 0.000 |
| 38 | Fatty acid elongation | 23 | 1.000 | 0.474 | 0.000 |
This table shows the detailed results from the pathway analysis. In particular, the Total is the total number of compounds in the pathway; the Hits is the actually matched number from the user uploaded data; the Impact is the pathway impact value calculated from pathway topology analysis